Sinnaeve, Peter R <br/><br/>
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS.  [electronic resource] 

 -  American heart journal  Oct 2006 
 - 684.e1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2006.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Aging<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Hemorrhage--etiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>Odds Ratio<br/>Randomized Controlled Trials as Topic<br/>Risk Assessment<br/>Treatment Outcome